← Back

Brother Enterprises Holding Co Ltd

Brother Enterprises Holding Co., Ltd. researches, develops, produces, and sells fine chemicals in China and internationally. Its products include vitamins for feed, food, daily chemicals, and pharmaceuticals; fragrance and flavour products; active pharmaceutical ingredients; chromium salts; leather chemicals; chromium tanning agents; hydroquinone; vanillin and ethyl vanillin; and iodine contrast agents. The company was formerly known as Haining Leather Chemicals Factory. Founded in 1991, it is headquartered in Haining, China.

Price · split & dividend adjusted
News & notes moving 002562.CS
002562.CS

Brother Technology's 2026 interim report shows net profit of 98.0306 million yuan

Brother Technology released its 2026 interim report, with total operating revenue of 2.061 billion yuan, net profit attributable to the parent company of 98.0306 million yuan, and net cash inflow from operating activities of 235 million yuan. The company's asset-liability ratio was 40.78%, gross margin was 19.44%, ROE was 2.69%, and diluted earnings per share was 0.09 yuan. The number of shareholders was 71,700, and the top ten shareholders held 42.17% of the total share capital.
Jiemian·21dRead more →
002562.CS

Brother Technology transfers 15.194% stake in Zhonghua Chemical for 150 million yuan, two lawsuits reach mediation

Brother Technology Co., Ltd. announced that, under the auspices of the Supreme People's Court, it has reached a package mediation plan with Jiaxing Zhonghua Chemical and Shanghai Xinchen regarding a technology secret infringement case and a share repurchase dispute case, and has received the Civil Mediation Document from the Supreme People's Court. The company transferred its 15.194% stake in Zhonghua Chemical to 10 other individual shareholders of Zhonghua Chemical for a total price of 150 million yuan, and the payment was received on August 25, 2026. At the same time, the company has withdrawn its lawsuit in the share repurchase dispute case, and the court has granted permission; Zhonghua Chemical and Shanghai Xinchen have abandoned all litigation claims in the technology secret infringement case and promised not to assert any rights against the company and Brother Pharmaceutical regarding the technology secrets involved. These two cases lasted for many years. In the technology secret infringement case, the Zhejiang Provincial High People's Court dismissed the plaintiff's claims at first instance, and the plaintiff appealed to the Supreme People's Court. In the share repurchase dispute case, the Nanhu District Court of Jiaxing dismissed the case at first instance, and the company appealed to the Jiaxing Intermediate People's Court. The company stated that this equity transfer is a non-trading equity investment, and the difference after deducting costs and expenses from the transfer proceeds will be recorded in retained earnings, with no impact on the company's profit.
Jiemian·24dRead more →
002562.CS

Brother Technology expects first-half 2026 net profit to rise 39.45% to 70.43% year-on-year

Brother Technology disclosed its earnings forecast, expecting net profit attributable to the parent company for the first half of 2026 to be between 90 million and 110 million yuan, a year-on-year increase of 39.45% to 70.43%. Net profit after deducting non-recurring items is expected to be between 85 million and 105 million yuan, up 35.93% to 67.92% year-on-year. Basic earnings per share are expected to be between 0.0788 yuan and 0.0936 yuan. The company stated that the earnings growth was mainly due to increased market demand for products such as vitamins and spices, while the company intensified efforts to develop new markets, leading to a year-on-year increase in sales volume of related products, a decrease in unit costs, and a rise in gross margin.
中国证券报·67dRead more →